Crinetics Pharmaceuticals Inc (CRNX)
Crinetics Pharmaceuticals Announces August 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Capricor Therapeutics Inc. (CAPR)
Capricor Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Maravai LifeSciences Holdings LLC (MRVI)
Maravai LifeSciences Reports Second Quarter 2025 Financial Results
IDEXX Laboratories Inc. (IDXX)
Denali Therapeutics (DNLI)
Biomarin Pharmaceutical Inc (BMRN)
Azitra Inc (AZTR)
Doximity Inc (DOCS)
Establishment Labs Holdings Inc (ESTA)
Omeros Corporation (OMER)
Omeros Corporation to Announce Second Quarter Financial Results on August 14, 2025
Enanta Pharmaceuticals Inc (ENTA)
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2025
Denali Therapeutics (DNLI)
Denali Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights
TELA Bio Inc. (TELA)
TELA Bio Reports Second Quarter 2025 Financial Results
Gevo Inc. (GEVO)
Gevo Reports Second Quarter 2025 Financial Results